Immunethep Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 18

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Latest Deal Amount
  • $2.45M

  • Investors
  • 5

Immunethep General Information

Description

Operator of a biotechnology company intended to develop bacterial immunotherapies based on the discovery of a virulence mechanism shared by different bacteria that cause life-threatening infections. The company offers therapies including the development of neonatal vaccines to protect neonates from bacterial infections inside the mother's womb. thereby enabling patients to develop their immunity and prevent multi-bacterial infections and diseases through advanced healthcare methods.

Contact Information

Website
www.immunethep.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • Biocant Park - Núcleo 04 Lote 3
  • Cantanhede, 3060-197
  • Portugal

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Immunethep Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Accelerator/Incubator 18-Oct-2022 $2.45M 00000 Completed Generating Revenue
6. Later Stage VC 00000 Completed Generating Revenue
5. Early Stage VC 18-Oct-2018 00000 00000 00.000 Completed Generating Revenue
4. Grant 23-Oct-2017 000.00 Completed Generating Revenue
3. Grant 31-Mar-2017 00000 Completed Startup
2. Seed Round 30-Mar-2015 Completed Startup
1. Spin-Off 06-Oct-2013 Completed Startup
To view Immunethep’s complete valuation and funding history, request access »

Immunethep Patents

  • 1

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 000

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Immunethep Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3967326-A1 Immunogenic compositions Inactive 10-Sep-2020 000000000

Immunethep Executive Team (7)

Name Title Board Seat Contact Info
Bruno Santos Co-Founder & Chief Executive Officer
Pedro Madureira Ph.D Co-Founder, Chief Scientific Officer & Board Member
Agostinho João Almeida Ph.D Co-Founder
Rafael Simao Co-Founder
Eric Leire MD Chairman & President of the Board of Directors
You’re viewing 5 of 7 executive team members. Get the full list »

Immunethep Board Members (3)

Name Representing Role Since
Eric Leire MD Self Chairman & President of the Board of Directors 000 0000
Pedro Madureira Ph.D Immunethep Co-Founder, Chief Scientific Officer & Board Member 000 0000
You’re viewing 2 of 3 board members. Get the full list »

Immunethep Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Immunethep Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
European Innovation Council Fund Venture Capital Minority 000 0000 000000 0
Bill & Melinda Gates Foundation Not-For-Profit Venture Capital 000 0000 000000 0
European Commission Government 000 0000 000000 0
Portugal Ventures Venture Capital Minority 000 0000 000000 0
Venture Catalysts Accelerator/Incubator Minority 000 0000 000000 0
To view Immunethep’s complete investors history, request access »

Ready to get started?

Request a free trial